Industry Overview of Genotyping Market
IMARC Group, a leading market research company, has recently releases report titled “Genotyping Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Genotyping market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is The Genotyping Market?
The global genotyping market size reached US$ 17.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 14.2% during 2023-2028.
What are Genotyping?
Genotyping is a crucial analytical procedure used to investigate the genetic makeup and DNA sequences of living organisms, including animals, microorganisms, humans, and plants. By examining genetic variations such as single nucleotide polymorphisms (SNPs) and changes in DNA, genotyping enables scientists to identify and understand a range of genetic deviations through biological assays. The applications of genotyping extend beyond research and diagnostics. It plays a significant role in preventing the spread of bacterial and viral diseases by accurately identifying their sources. Genotyping also offers the advantage of reducing unnecessary medical checkups and provides valuable insights for informed treatment options. Furthermore, genotyping is recognized for its cost-effectiveness, flexibility, reliability, and simplicity.
Given these advantages, genotyping has gained widespread adoption in various sectors, including academic institutes, diagnostics and research laboratories, and the pharmaceutical and biopharmaceutical industries. Its use has become integral to advancing scientific knowledge, improving diagnostics, and developing innovative therapies and treatments.
What Are The Growth Prospects And Trends In The Genotyping Industry?
The genotyping market is experiencing significant growth driven by various factors. One of the primary drivers is the expanding healthcare sector, coupled with the increasing prevalence of genetic disorders and cancers. Additionally, the growing elderly population, who are more susceptible to developing various medical conditions, is contributing to the market's expansion. The outbreak of the COVID-19 pandemic has also played a role in boosting the demand for genotyping kits, further fueling market growth. Furthermore, the utilization of single nucleotide polymorphisms (SNPs) to detect and understand the underlying causes of diseases like asthma, cancer, cardiovascular disorders, and Alzheimer's is driving market growth.
The adoption of bioinformatic solutions for data analysis and the integration of genotyping in pharmacogenomics for drug discovery processes are also propelling market growth. Moreover, there is increasing awareness among individuals about personalized medicine, leading to a greater demand for genotyping. The significant investments in research and development (R&D) activities focused on genomic drug development and precision medicine research are creating a favorable market environment worldwide.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Product and Service:
Instruments
Reagents and Kits
Software and Services
Breakup by Technology:
Polymerase Chain Reaction (PCR)
Capillary Electrophoresis
Microarray
Sequencing
Mass Spectrometry
Others
Breakup by Application:
Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others
Breakup by End User:
Pharmaceutical and Biopharmaceutical Companies
Diagnostics and Research Laboratories
Academic Institutes
Others
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Danaher Corporation
Eurofins Scientific SE, F. Hoffmann-La Roche AG
Illumina Inc.
Laboratory Corporation of America Holdings
Qiagen N.V
Standard BioTools Inc.
and Thermo Fisher Scientific Inc.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/